| 1 |
Jemal A, Bray F, Center MM, et al. Global cancer statistics [J]. CA Cancer J Clin, 2011, 61(2):69-90.
|
| 2 |
Waki K, Aikata H, Katamura Y, et al. Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: results and prognostic factors on long-term follow up [J]. J Gastroenterol Hepatol, 2010, 25(3):597-604.
|
| 3 |
Moschouris H, Malagari K, Papadaki MG, et al. mRECIST criteria and contrast-enhanced US for the assessment of the response of hepatocellular carcinoma to transarterial chemoembolization [J]. Diagn Interv Radiol, 2014, 20(2):136-142.
|
| 4 |
Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma [J]. Semin Liver Dis, 2010, 30(1):52-60.
|
| 5 |
Meloni MF, Andreano A, Franza E, et al. Contrast enhanced ultrasound: Should it play a role in immediate evaluation of liver tumors following thermal ablation? [J]. Eur J Radiol, 2012, 81(8):e897-e902.
|
| 6 |
Moschouris H, Malagari K, Papadaki MG, et al. mRECIST criteria and contrast-enhanced US for the assessment of the response of hepatocellular carcinoma to transarterial chemoembolization [J]. Diagn Interv Radiol, 2014, 20(2):136-142.
|
| 7 |
Nicolau C, Vilana R, Bianchi L, et al. Early-stage hepatocellular carcinoma: the high accuracy of real-time contrast-enhanced ultrasonography in the assessment of response to percutaneous treatment [J]. Eur Radiol, 2007, 17 Suppl 6:F80-F88.
|
| 8 |
Lekht I, Gulati M, Nayyar M, et al. Role of contrast-enhanced ultrasound (CEUS) in evaluation of thermal ablation zone [J]. Abdom Radiol (NY), 2016, 41(8):1511-1521.
|
| 9 |
Nishigaki Y, Hayashi H, Tomita E, et al. Usefulness of contrast-enhanced ultrasonography using Sonazoid for the assessment of therapeutic response to percutaneous radiofrequency ablation for hepatocellular carcinoma [J]. Hepatol Res, 2015, 45(4):432-440.
|
| 10 |
Liu M, Lin MX, Lu MD, et al. Comparison of contrast-enhanced ultrasound and contrast-enhanced computed tomography in evaluating the treatment response to transcatheter arterial chemoembolization of hepatocellular carcinoma using modified RECIST [J]. Eur Radiol, 2015, 25(8):2502-2511.
|
| 11 |
Cho YZ, Park SY, Choi EH, et al. The usefulness of contrast-enhanced ultrasonography in the early detection of hepatocellular carcinoma viability after transarterial chemoembolization: pilot study [J]. Clin Mol Hepatol, 2015, 21(2):165-174.
|
| 12 |
Takizawa K, Numata K, Morimoto M, et al. Use of contrast-enhanced ultrasonography with a perflubutane-based contrast agent performed one day after transarterial chemoembolization for the early assessment of residual viable hepatocellular carcinoma [J]. Eur J Radiol, 2013, 82(9):1471-1480.
|
| 13 |
Granata V, de Lutio di Castelguidone E, Fusco R, et al. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area [J]. Radiol Med, 2016, 121(2):122-131.
|
| 14 |
Du J, Li HL, Zhai B, et al. Radiofrequency ablation for hepatocellular carcinoma: utility of conventional ultrasound and contrast-enhanced ultrasound in guiding and assessing early therapeutic response and short-term follow-up results [J]. Ultrasound Med Biol, 2015, 41(9):2400-2411.
|
| 15 |
Shaw CM, Eisenbrey JR, Lyshchik A, et al. Contrast-enhanced ultrasound evaluation of residual blood flow to hepatocellular carcinoma after treatment with transarterial chemoembolization using drug-eluting beads: a prospective study [J]. J Ultrasound Med, 2015, 34(5):859-867.
|
| 16 |
Ayuso C, Rimola J, Garcia-Criado A. Imaging of HCC [J]. Abdom Imaging, 2012, 37(2):215-230.
|
| 17 |
Wang Z, Wang W, Liu GJ, et al. The role of quantitation of real-time 3-dimensional contrast-enhanced ultrasound in detecting microvascular invasion: an in vivo study [J]. Abdom Radiol (NY), 2016, 41(10):1973-1979.
|
| 18 |
Kaufmann S, Schulze M, Spira D, et al. Comparison of volume perfusion computed tomography and contrast-enhanced ultrasound for assessment of therapeutic effect of transarterial chemoembolization in patients with hepatocellular carcinoma: a preliminary report [J]. Acta Radiol, 2016, 57(1):8-12.
|
| 19 |
Ippolito D, Bonaffini PA, Capraro C, et al. Viable residual tumor tissue after radiofrequency ablation treatment in hepatocellular carcinoma: evaluation with CT perfusion [J]. Abdom Imaging, 2013, 38(3):502-510.
|
| 20 |
Zhu AX, Duda DG, Sahani DV, et al. HCC and angiogenesis: possible targets and future directions [J]. Nat Rev Clin Oncol, 2011, 8(5):292-301.
|
| 21 |
Choi JI, Imagawa DK, Bhosale P, et al. Magnetic resonance imaging following treatment of advanced hepatocellular carcinoma with sorafenib [J]. Clin Mol Hepatol, 2014, 20(2):218-222.
|
| 22 |
Watanabe R, Munemasa T, Matsumura M. Contrast-enhanced ultrasound with perflubutane in the assessment of anti-angiogenic effects: early prediction of the anticancer activity of bevacizumab in a mouse xenografted model [J]. Ultrasound Med Biol, 2015, 41(9):2497-2505.
|
| 23 |
Piscaglia F, Cucchetti A, Dietrich CF, et al. Towards new tools for refined management of patients with advanced hepatocellular carcinoma under systemic therapy: some enthusiasm with a word of caution [J]. J Hepatol, 2013, 59(5):924-925.
|
| 24 |
Lo GM, Al ZH, Jang HJ, et al. Detection of Early Tumor Response to Axitinib in Advanced Hepatocellular Carcinoma by Dynamic Contrast Enhanced Ultrasound [J]. Ultrasound Med Biol, 2016, 42(6):1303-1311.
|
| 25 |
Lassau N, Coiffier B, Faivre L, et al. Study of Intrapatient Variability and Reproducibility of Quantitative Tumor Perfusion Parameters Evaluated With Dynamic Contrast-Enhanced Ultrasonography [J]. Invest Radiol, 2017, 52(3):148-154.
|
| 26 |
Mauri G, Cova L, De Beni S, et al. Real-time US-CT/MRI image fusion for guidance of thermal ablation of liver tumors undetectable with US: results in 295 cases [J]. Cardiovasc Intervent Radiol, 2015, 38(1):143-151.
|
| 27 |
Li K, Su ZZ, Xu EJ, et al. Improvement of ablative margins by the intraoperative use of CEUS-CT/MR image fusion in hepatocellular carcinoma [J]. BMC Cancer, 2016, 16:277.
|
| 28 |
Makino Y, Imai Y, Igura T, et al. Feasibility of Extracted-Overlay Fusion Imaging for Intraoperative Treatment Evaluation of Radiofrequency Ablation for Hepatocellular Carcinoma [J]. Liver Cancer, 2016, 5(4):269-279.
|
| 29 |
Wang Y, Jing X, Ding J. Clinical value of dynamic 3-dimensional contrast-enhanced ultrasound imaging for the assessment of hepatocellular carcinoma ablation [J]. Clin Imaging, 2016, 40(3):402-406.
|
| 30 |
Bartolotta TV, Taibbi A, Matranga D, et al. 3D versus 2D contrast-enhanced sonography in the evaluation of therapeutic response of hepatocellular carcinoma after locoregional therapies: preliminary findings [J]. Radiol Med, 2015,120(8):695-704.
|
| 31 |
朱晓琳，刘辰，张雪君. 增强CT、MRI与超声对肝脏局灶性病变诊断的比较研究 [J]. 国际医学放射学杂志, 2014, 14(4):342-346.
|
| 32 |
Guibal A, Bertin C, Egels S, et al. Contrast-enhanced ultrasound (CEUS) follow-up after radiofrequency ablation or cryoablation of focal liver lesions: treated-area patterns and their changes over time [J]. Eur Radiol, 2013, 23(5):1392-1400.
|
| 33 |
Yu H, Jang HJ, Kim TK, et al. Pseudoenhancement within the local ablation zone of hepatic tumors due to a nonlinear artifact on contrast-enhanced ultrasound [J]. AJR Am J Roentgenol, 2010, 194(3):653-659.
|
| 34 |
严昆. 肝癌消融后超声及超声造影评价疗效 [J]. 中华医学杂志, 2015, 95(27):2154-2156.
|